Effect of low dose dexmedetomidine combined with music therapy on the median effective dose of sufentanil for tracheal intubation

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400083861

Enrollment

Unknown

Registered

2024-05-06

Start date

2024-05-06

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Diseases

Interventions

control group:normal saline

dexmedetomidine group:dexmedetomidine

dexmedetomidine combined with music therapy group:Dexmedetomidine combined with music therapy

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing elective surgery under general anesthesia with tracheal intubation were classified as ASA grade I-II; (2) Age 18-60; (3) BMI 18-30 kg/m²; (4) Normal communication; (5) Volunteer and sign the informed consent

Exclusion criteria

Exclusion criteria: (1) Serious respiratory and circulatory diseases: such as severe coronary heart disease, COPD, severe sinus bradycardia (HR 25 seconds

Design outcomes

Primary

Measure	Time frame
The median effective dose of sufentanil for tracheal intubation;	—

Secondary

Measure	Time frame
Hemodynamic parameters;vasoactive drugs;Complications;The dose of sedative and analgesic;Sedative score;The duration of PACU and extubation time;	—

Countries

China

Contacts

Public ContactRui xiao

Fuyang Hospital affiliated to Anhui Medical University

xiaorui8353@163.com+86 136 6569 8353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026